Pulmonary Disease Doctors in Watertown, NY Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Mr. Marco Alfredo Campitelli, M.D Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 830 Washington St, Watertown, NY 13601 Phone: 315-785-4000

Dr. David Paul Rechlin, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 19320 Us Route 11, Watertown, NY 13601 Phone: 315-786-0254    Fax: 315-786-0976

Vivian Keenan, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 19320 Us Route 11, Watertown, NY 13601 Phone: 315-786-0254

Dr. Lawrence George Kramer, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 19320 Us Route 11, Watertown, NY 13601 Phone: 315-786-0254    Fax: 315-786-0976

Dr. Rory Allayn Sears, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 19320 Us Route 11, Watertown, NY 13601 Phone: 315-786-0254

News Archive

Research brings hope of new treatment for asthma patients resistant to corticosteroids

New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.

In-depth analysis of health law decision

News outlet examine how constitutional issues, most notably the Commerce Clause, are central to the health law and its journey to the nation's highest court. Meanwhile, the Associated Press offers insights into Judge Vinson's own experiences with the health system.

Researchers uncover surprising new role for inhibition in the cerebellum

Almost everyone is familiar with the unique mixture of surprise and confusion that occurs after making a mistake during an everyday movement.

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

Read more Medical News

› Verified 3 days ago